Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb)

被引:101
作者
Lee, LYL [1 ]
Liang, XW [1 ]
Höök, M [1 ]
Brown, EL [1 ]
机构
[1] Texas A&M Univ Syst, Hlth Sci Ctr, Ctr Extracellular Matrix Biol, Albert B Alkek Inst Biosci & Technol, Houston, TX 77030 USA
关键词
D O I
10.1074/jbc.M408570200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The secreted Staphylococcus aureus extracellular fibrinogen-binding protein (Efb) is a virulence factor that binds to both the complement component C3b and fibrinogen. Our laboratory previously reported that by binding to C3b, Efb inhibited complement activation and blocked opsonophagocytosis. We have now located the Efb binding domain in C3b to the C3d fragment and determined a disassociation constant (K-d) of 0.24 muM for the Efb-C3d binding using intrinsic fluorescence quenching assays. Using truncated, recombinant forms of Efb, we also demonstrate that the C3b binding region of Efb is located within the C terminus, in contrast to the fibrinogen binding domains that are located at the N-terminal end of the protein. Enzyme-linked immunosorbent assay-type binding assays demonstrated that recombinant Efb could bind to both C3b and fibrinogen simultaneously, forming a trimolecular complex and that the C-terminal region of Efb could inhibit complement activity in vitro. In addition, secondary structure analysis using circular dichroism spectroscopy revealed that the C-terminal, C3b binding region of Efb is composed primarily of alpha-helices, suggesting that this domain of Efb represents a novel type of C3b-binding protein.
引用
收藏
页码:50710 / 50716
页数:7
相关论文
共 80 条
[31]  
3.0.CO
[32]  
2-2
[33]   THE MULTIFUNCTIONAL ROLE OF C-3, THE 3RD COMPONENT OF COMPLEMENT [J].
LAMBRIS, JD .
IMMUNOLOGY TODAY, 1988, 9 (12) :387-393
[34]   The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses [J].
Lee, LY ;
Miyamoto, YJ ;
McIntyre, BW ;
Höök, M ;
McCrea, KW ;
McDevitt, D ;
Brown, EL .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (10) :1461-1471
[35]   Inhibition of complement activation by a secreted Staphylococcus aureus protein [J].
Lee, LYL ;
Höök, M ;
Haviland, D ;
Wetsel, RA ;
Yonter, EO ;
Syribeys, P ;
Vernachio, J ;
Brown, EL .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (03) :571-579
[36]   Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia [J].
Lina, G ;
Piémont, Y ;
Godail-Gamot, F ;
Bes, M ;
Peter, MO ;
Gauduchon, V ;
Vandenesch, F ;
Etienne, J .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) :1128-1132
[37]   Medical progress -: Staphylococcus aureus infections [J].
Lowy, FD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (08) :520-532
[38]   Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo [J].
Lubinski, JM ;
Wang, LY ;
Soulika, AM ;
Burger, R ;
Wetsel, RA ;
Colten, H ;
Cohen, GH ;
Eisenberg, RJ ;
Lambris, JD ;
Friedman, HM .
JOURNAL OF VIROLOGY, 1998, 72 (10) :8257-8263
[39]   Complement factor H: sequence analysis of 221 kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes [J].
Male, DA ;
Ormsby, RJ ;
Ranganathan, S ;
Giannakis, E ;
Gordon, DL .
MOLECULAR IMMUNOLOGY, 2000, 37 (1-2) :41-52
[40]  
Martínez-Aguilar G, 2003, PEDIATR INFECT DIS J, V22, P593, DOI 10.1097/00006454-200307000-00006